ABSTRACT
Abstract Treatment with plant is considered an effective option against increased antibiotic resistance. In this study antibiofilm activity of methanol (CH3OH), chloroform (CHCl3), ethyl acetate (EtOAc) and water (H2O) extracts of Hypericum atomarium Boiss. which is member of Hypericum genus was evaluated in Pseudomonas aeruginosa PAO1 and antibacterial performance against Gram (+) and Gram (-) strains and also bioactive compounds of extract were analysed using by HPLC and GC-MS. According to antibacterial activity test results the extracts were effective all Gram (+) bacteria and Gram (-) Chromobacterium violaceum (MICs ranging from 0.42 µg/ml to 4.3 mg). Inhibition effect of biofilm formation was found to be different rate in extracts (methanol-63%, chloroform-52%). The major flavonoids were detected (−)-epicatechin (2388.93 µg/ml) and (+)-catechin (788.94 µg/ml). The main phenolic acids were appeared as caffeic acid 277.34 µg/ml and chlorogenic acid 261.79 µg/ml. And according to GC results α-pinene was found main compound for three solvent extracts methanol, chloroform and ethyl acetate 67.05, 62.69, 49.28% rate respectively
Subject(s)
Plants/metabolism , In Vitro Techniques/methods , Biofilms/classification , Hypericum/classification , Sprains and Strains/complications , Chromatography, High Pressure Liquid/methods , Chromobacterium/isolation & purification , Acetates/classificationABSTRACT
Chromobacterium violaceum is a rare opportunistic pathogen that causes highly fatal infections in domestic animals and humans. This report describes a fatal case suggestive of septicemia in a four-day-old female calf with chromobacteriosis. The calf had suppurative omphalophlebitis, suppurative fibrinous polyarthritis, anterior uveitis with bilateral fibrin deposition, fibrinous peritonitis, lymph node abscess and multifocal lymphocytic and neutrophilic encephalitis with multifocal hemorrhages. C. violaceum was isolated from the spleen and peri-renal lymph node and its identity was confirmed by PCR and sequencing. The pathogen was sensitive to azithromycin, gentamicin, enrofloxacin, norfloxacin, marbofloxacin, ciprofloxacin, erythromycin, sulphazotrim, fluorfenicol, tetracycline and doxycycline as well as resistant to penicillin, ampicillin, vancomycin, amoxicillin, amoxicillin + clavulanic acid, cephalothin, cephalexin, oxacillin, B polymyxin, neomycin and bacitracin. This is the first report of chromobacteriosis in a calf from Brazil.(AU)
Chromobacterium violaceum é um patógeno oportunista raro, que causa infecção fatal em animais domésticos e em humanos. Este relato descreve um caso fatal suspeito de septicemia em um bezerro de quatro dias, fêmea, infectado por C. violaceum. O bezerro apresentava onfaloflebite supurativa, poliartrite supurativa fibrinosa, uveíte anterior com deposição bilateral de fibrina, peritonite fibrinosa, abscesso de linfonodos e encefalite multifocal linfocítica e neutrofílica com áreas hemorrágicas multifocais. C. violaceum foi isolado no baço e no linfonodo, e sua identidade foi confirmada por PCR e sequenciamento. O patógeno foi sensível aos antibióticos azitromicina, gentamicina, enrofloxacina, norfloxacina, marbofloxacina, ciprofloxacina, eritromicina, sulfazotrim, florfenicol, tetraciclina, doxiciclina e foi resistente à penicilina, ampicilina, vancomicina, amoxicilina, amoxicilina + ácido clavulânico, cefalotina, cefalexina, oxacilina, polimixina B, neomicina e bacitracina. Este é o primeiro relato de cromobacteriose em bezerro no Brasil.(AU)
Subject(s)
Animals , Female , Cattle , Arthritis/veterinary , Uveitis/veterinary , Chromobacterium/isolation & purification , Sepsis/veterinary , Polymerase Chain Reaction/veterinaryABSTRACT
Chromobacterium violaceum es una bacteria gram negativa anaerobia facultativa, que se encuentra ampliamente distribuida en el agua y el suelo en regiones tropicales y subtropicales, que se asocia con infecciones respiratorias, gastrointestinales, abscesos hepáticos, meningitis, endocarditis, síndrome hemofagocítico y sepsis fulminante. Se presentan 2 casos en niños: el primero es un varón de 8 años con lesiones en piel, fiebre y adenitis inguinal, que ingresó con un cuadro de sepsis severa, síndrome de distrés respiratorio agudo (SDRA) y falleció a las 3 h del ingreso. De los hemocultivos se aisló Chromobacterium violaceum. El segundo caso, es una niña de 12 años con antecedente de fiebre y adenopatía inguinal secundaria a herida cortopunzante en el pie homolateral, que ingresó con un cuadro de sepsis, con desarrollo de abscesos múltiples profundos. De la colección obtenida de piel y partes blandas y de un aspirado traqueal se aisló Chromobacterium violaceum. Recibió tratamiento antibiótico adecuado y posteriormente fue dada de alta. Se realizó una revisión bibliográfica de esta infección en niños y se encontraron 44 casos en todo el mundo. Algunos de éstos, se relacionaron con inmunodeficiencia de base, como la enfermedad granulomatosa crónica. La infección por esta bacteria es rara y se presenta como un cuadro grave que no responde a antibióticos habituales de uso empírico y tiene una alta tasa de mortalidad (AU)
Chromobacterium violaceum is a facultative anaerobic Gramnegative bacillus, widely distributed in water and soil in tropical and subtropical regions and associated with respiratory and gastrointestinal infections, liver abscesses, meningitis, endocarditis, hemophagocytic syndrome, and fulminant sepsis. Here two pediatric cases are presented: The first was an 8-year-old boy with skin lesions, fever, and inguinal adenitis, who was admitted with severe sepsis, acute respiratory distress syndrome (ARDS) and died three hours after. Chromobacterium violaceum was isolated from blood cultures. The second case was a 12-year-old girl with a history of fever and inguinal adenopathy secondary to a wound in the homolateral foot, who was admitted because of sepsis and multiple deep abscesses. From samples collected from the skin and soft tissues as well as tracheal aspirate Chromobacterium violaceum was isolated. Adequate antibiotic treatment was started and the patient was subsequently discharged. In a review of the literature, 44 cases worldwide were identified. Some of these cases were related to underlying immunodeficiency, such as chronic granulomatous disease. Infection with this bacterium is rare and presents with severe manifestations that do not respond to the common empirical antibiotics and are associated with a high mortality rate (AU)
Subject(s)
Humans , Child , Chromobacterium/isolation & purification , Gram-Negative Bacterial Infections/microbiology , Sepsis/microbiology , Anti-Bacterial Agents/therapeutic use , Mortality , Treatment Outcome , Gram-Negative Bacterial Infections/diagnosis , Gram-Negative Bacterial Infections/drug therapy , Sepsis/diagnosis , Sepsis/drug therapyABSTRACT
Phytases are a group of enzymes that catalyze phytic acid hydrolysis with release of phosphorus (P). The ability of Chromobacterium sp. to produce phytase was detected in 115 out of 118 candidate bacteria isolated from different Brazilian biomas. This is the first report revealing the genus Chromobacterium as phytase producer.
Subject(s)
Base Sequence , Biomass , Chromobacterium/enzymology , Chromobacterium/isolation & purification , Environmental Microbiology , Enzyme Reactivators , Eutrophication , Phosphoric Monoester Hydrolases , Peptide Hydrolases/analysis , Catalysis , Enzyme Activation , Genetic Variation , Hydrolysis , Methods , Methods , Tropical EcosystemABSTRACT
Chromobacterium violaceum is a rare pathogen that can cause potentially fatal infections in humans. Till date, 150 cases are reported worldwide including 7 from India. We report a 6 month old infant who presented with high grade fever, respiratory distress and multiple vesicular skin lesions. Chromobacterium violaceum was isolated from blood, bone marrow aspirate and from skin lesions. Infant responded to treatment with piperacillin and ciprofloxacin, and is doing well on follow up.
Subject(s)
Anti-Bacterial Agents/therapeutic use , Chromobacterium/isolation & purification , Gram-Negative Bacterial Infections/drug therapy , Gram-Negative Bacterial Infections/microbiology , Humans , Infant , Male , Sepsis/drug therapy , Sepsis/microbiologySubject(s)
Anti-Bacterial Agents/therapeutic use , Bacteremia/diagnosis , Chromobacterium/isolation & purification , Fatal Outcome , Gentamicins/therapeutic use , Gram-Negative Bacterial Infections/diagnosis , Hospitals, Public , Humans , Infant , Male , Protein Synthesis Inhibitors/therapeutic use , Sri Lanka , Thienamycins/therapeutic useABSTRACT
Chromobacterium violaceum infection in humans is a rare tropical and subtropical disease. The awareness of this organism is limited in spite its ubiquitous distribution. Several cases have been reported from Southeast Asia. A localized infection followed by an overwhelming septicemia and metastatic lesions is the usual pattern of this illness. Optimal antimicrobial treatment and duration are unknown. Consequently, the outcome is usually fatal. The study reported two patients who suffered from fulminant Chromobacterium violaceum sepsis with disseminated infection, and reviews the literature for cases reported from Southeast Asia.
Subject(s)
Anti-Infective Agents/therapeutic use , Asia, Southeastern , Bacteremia/drug therapy , Child , Chromobacterium/isolation & purification , Fatal Outcome , Female , Gram-Negative Bacterial Infections/drug therapy , Humans , Male , Middle AgedABSTRACT
A 4-year old child living in Colombia presented with a history of fever and severe abdominal pain for four days. The patient developed pneumonia, septic shock, multiple organ failure and died on the fifth day of hospitalization. Chromobacterium violaceum was isolated from admission blood cultures and was resistant to ampicillin, cephalosporins, carbapenems and aminoglycosides.
Una niña de 4 años que vivía en Colombia presentó historia de fiebre y dolor abdominal severo por cuatro días. La paciente desarrollo neumonía, shock séptico, múltiple falla de órganos y muerte el quinto día de hospitalización. Chromobacterium violaceum fue aislado de cultivos de sangre y mostró resistencia a ampicilina, cefalosporinas, carbapenems y aminoglicosidos.
Subject(s)
Child, Preschool , Female , Humans , Bacteremia/microbiology , Chromobacterium/isolation & purification , Gram-Negative Bacterial Infections/microbiology , Fatal Outcome , Gram-Negative Bacterial Infections/diagnosisABSTRACT
La sepsis por Chromobacterium violaceum es un cuadro clínico rara vez reportado y asociado con una elevada letalidad. Comunicamos un caso fatal de sepsis en un niño indígena venezolano con 6 años de edad, quien presentó fiebre y aumento de volumen en la región inguinal derecha y que fuera inicialmente diagnosticado como plastrón apendicular abscedado. La cirugía de apendicetomía reveló un absceso en el músculo psoas derecho, del cual se aisló una cepa pigmentada de C. violaceum, mientras que a partir de hemocultivos se aislaron cepas pigmentada y no pigmentada, simultáneamente, del mismo agente. Se administró tratamiento con imipenem y amikacina pero su condición se deterioró y falleció a los 9 días de su ingreso.
Chromobacterium violaceum sepsis is rare but associated with a high mortality rate. We report a fatal case of C. violaceum sepsis in a 6 years old Venezuelan indian boy. Clinical manifestations were fever and swelling in the right inguinal region. The initial diagnosis was an appendicular plastron. Appendicectomy was performed and during surgery a right psoas abscess was identified that resulted culture positive for pigmented C. violaceum. Blood cultures were positive for a pigmented and non pigmented C. violaceum strain. Imipenem and amikacin were administered despite of which the child died 9 days after hospital admission.
Subject(s)
Humans , Infant , Male , Chromobacterium/isolation & purification , Gram-Negative Bacterial Infections/microbiology , Psoas Abscess/microbiology , Sepsis/microbiology , Amikacin/therapeutic use , Anti-Bacterial Agents/therapeutic use , Fatal Outcome , Gram-Negative Bacterial Infections/diagnosis , Gram-Negative Bacterial Infections/drug therapy , Indians, South American , Imipenem/therapeutic use , Psoas Abscess/diagnosis , Psoas Abscess/drug therapy , Sepsis/diagnosis , Sepsis/drug therapyABSTRACT
Human infection caused by Chromobacterium violaceum is rare but when it occurs, it is associated with a high mortality rate. This is a report of a young adult male who presented as a surgical emergency and succumbed soon after. The most common feature of this infection is sepsis, followed by cutaneous involvement and liver abscesses. Chromobacterium infection as a differential in a case of sepsis is important for clinicians to suspect, especially in tropical countries.
Subject(s)
Adult , Humans , Male , Chromobacterium/isolation & purification , Gram-Negative Bacterial Infections/complications , Sepsis/etiology , Ceftriaxone/therapeutic use , Fatal Outcome , Gram-Negative Bacterial Infections/microbiology , Metronidazole/therapeutic useABSTRACT
Chromobacterium violaceum is found in tropical and subtropical regions; it is the only Chromobacterium species pathogenic for humans. Due to its rare presentation, physicians often ignore the importance of this pathogen. We report a fulminant fatal case of bacteremia in a 38-year-old Colombian man. The clinical manifestations were fever, thoracic pain, respiratory failure and death. His condition, from the beginning of clinical diagnosis, went into continuous deterioration, till his death, within a few days after the symptoms began. Two hemocultures isolated C. violaceum. We conclude that doctors should consider this differential diagnosis in patients with systemic inflammatory response syndrome, with continuous deterioration.
Subject(s)
Adult , Humans , Male , Bacteremia/microbiology , Chromobacterium/isolation & purification , Gram-Negative Bacterial Infections/microbiology , Bacteremia/drug therapy , Bacteremia/epidemiology , Colombia/epidemiology , Fatal Outcome , Gram-Negative Bacterial Infections/drug therapy , Gram-Negative Bacterial Infections/epidemiologyABSTRACT
Human infections by Chromobacterium violaceum are rare. Till date 6 cases have been reported from southern and eastern parts of India. We report here a case of puerperal sepsis by C. violaceum, probably the first case from Eastern part of Orissa. The patient was successfully treated with amikacin and gatifloxacin.
Subject(s)
Academic Medical Centers , Adult , Amikacin/therapeutic use , Anti-Bacterial Agents , Chromobacterium/isolation & purification , Female , Fluoroquinolones/therapeutic use , Gram-Negative Bacterial Infections/diagnosis , Humans , India , Puerperal Infection/diagnosis , Sepsis/diagnosisABSTRACT
Em abril/2004, um grupo de pessoas realizou passeio a um sítio em cidade no baixo sul da Bahia e em seguida três adolescentes de uma mesma família apresentaram septicemia grave com óbito de dois destes. Objetivando identificar o evento, o Servico de Vigilância procedeu à investigacão epidemiológica, clínica, laboratorial e ambiental, identificando a Chromobacterium violaceum em material biológico de um dos pacientes que evoluíram para óbito e na água e solo do local do passeio. Esta é o primeira descricão desta doenca na Bahia.
Subject(s)
Child , Adolescent , Humans , Male , Chromobacterium/isolation & purification , Gram-Negative Bacterial Infections/diagnosis , Sepsis/microbiology , Brazil/epidemiology , Disease Outbreaks , Gram-Negative Bacterial Infections/drug therapy , Gram-Negative Bacterial Infections/epidemiology , Gram-Negative Bacterial Infections/microbiology , Severity of Illness IndexABSTRACT
Chromobacterium violaceum is a gram negative straight rod, 0.8-1.2 by 2.5 to 6.0 m, which is motile by one polar flagella and one to four lateral flagella. The organism inhabits soil and water and is often found in semitropical and tropical climates. Infections in humans are rare. We report a case of infection caused by strains of C. violaceum. A 38-year-old male patient was admitted to KyungHee University Hospital, Seoul, Korea on July 28th, 2003, after a car accident. The patient had multiple trauma and lacerations. He had an open wound in the left tibial area from which C. violaceum was isolated. The strain was resistant to ampicillin, tobramycin, ampicillin/sulbactam, ceftriaxone and cefepime, but was susceptible to amikacin, gentamicin, ciprofloxacin, levofloxacin, trimethoprim/sulfamethoxazole and piperacillin/tazobactam. The patient was treated successfully by debridement, cephapirin sodium and astromicine sulfate.
Subject(s)
Male , Humans , Adult , Wound Infection/etiology , Gram-Negative Bacterial Infections/etiology , Chromobacterium/isolation & purification , Accidents, TrafficABSTRACT
Chromobacterium violaceum is an extremely rare human pathogen. We report a rare case of septicemia with multiple abscesses and otitis media in a newborn caused by chromobacterium violaceum.
Subject(s)
Bacteremia/microbiology , Chromobacterium/isolation & purification , Fatal Outcome , Gram-Negative Bacterial Infections/microbiology , Humans , Infant, Newborn , Otitis Media, Suppurative/microbiology , Suppuration/microbiologyABSTRACT
We report the second case of infection with Chromobacterium violaceum that occurred in Brazil. A farm worker living in the State of São Paulo presented fever and severe abdominal pain for four days. At hospitalization the patient was in a toxemic state and had a distended and painful abdomen. Chest X-ray and abdominal ultrasound revealed bilateral pneumonia and hypoechoic areas in the liver. The patient developed failure of multiple organs and died a few hours later. Blood culture led to isolation of C. violaceum resistant to ampicillin and cephalosporins and sensitive to chloramphenicol, tetracyclin, aminoglicosydes, and ciprofloxacin. Autopsy revealed pulmonary microabscesses and multiple abscesses in the liver. The major features of this case are generally observed in infections by C. violaceum: rapid clinical course, multiple visceral abscesses, and high mortality. Because of the antimicrobial resistance profile of this Gram-negative bacillus, for appropriate empirical antibiotic therapy it is important to consider chromobacteriosis in the differential diagnosis of severe community infections in Brazil.
Subject(s)
Humans , Male , Adult , Chromobacterium , Gram-Negative Bacterial Infections/diagnosis , Anti-Bacterial Agents/therapeutic use , Chromobacterium/isolation & purification , Drug Resistance, Microbial , Gram-Negative Bacterial Infections/drug therapy , Liver Abscess/diagnosis , Liver Abscess/microbiologySubject(s)
Humans , Chromobacterium/isolation & purification , Chromobacterium/pathogenicity , Chromobacterium/ultrastructure , Granulomatous Disease, Chronic/complications , Granulomatous Disease, Chronic/diagnosis , Granulomatous Disease, Chronic/etiology , Granulomatous Disease, Chronic/physiopathologyABSTRACT
Chromobacterium violaceum, Brazilian or Chilean strain, produces a pigment 3 [1,2-dihydro-5 (5-hydroxy-JH-indo) 2-oxo-3H-pyrrol-3-ylidene] 1,3-dihydro-2H-indol-2-one (Violacein). Violacein was isolated from acetone extract in both cases and identified by ultraviolet-visible., infrared, nuclear magnetic rosonance spectroscopy and by mass spectrometry. A derivative of violacein, the tetracetyl-violacein was synthetized in order to confirm the violacein structure. The biosynthesis of C=violacein is also reported
Subject(s)
Anti-Bacterial Agents/isolation & purification , Chromobacterium/isolation & purification , Trypanocidal Agents/isolation & purification , Brazil , Chemistry , Chile , Pigments, BiologicalABSTRACT
Se describe un caso de septicemia fatal por Chromobacterium violaceum en un niño de nueve años de edad, proveniente de San Miguelito. La bacteria se aisló en abcesos de bazo, hígado, pulmones, osteomielitis de la tibia izquierda y en un hemocultivo tomado post-morten